Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Germany’s Boehringer Ingelheim has selected a third drug candidate to move forward into IND-enabling studies under its ongoing collaboration with Oxford BioTherapeutics.

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to educate people with bronchiectasis about how to better manage the disease.

What happens when data projects forget the people who use them? A Disconnect. Boehringer Ingelheim turned things around by ...

Sonelokimab, adalimumab, lutikizumab, and bimekizumab are the top-rated treatments for moderate-to-severe HS, a network ...

Analysts have recently evaluated Elanco Animal Health and provided 12-month price targets. The average target is $15.25, ...

Boehringer Ingelheim, a global leader in animal health, has announced the launch of its latest poultry vaccine in India–a single-dose, next-generation solution that provides protection against Bursal, ...

The site was created by Boehringer Ingelheim after a survey identified knowledge gaps among owners on many health topics ...

NORTHAMPTON, MA / ACCESS Newswire / June 16, 2025 / In remote communities in Argentina, access to quality healthcare is a challenge for many different reasons, including a strong reliance on paper ...

Boehringer Ingelheim launches innovative poultry vaccine in India, offering single-dose protection against major diseases, ...